Sekulovski M, Mileva N, Vasilev G, Miteva D, Gulinac M, Peshevska-Sekulovska M
Biomedicines. 2023; 11(10).
PMID: 37893186
PMC: 10604891.
DOI: 10.3390/biomedicines11102813.
Favaloro E, Pasalic L
Methods Mol Biol. 2023; 2663:405-415.
PMID: 37204726
DOI: 10.1007/978-1-0716-3175-1_26.
Hovi P, Palmu A, Nieminen T, Artama M, Jokinen J, Ruokokoski E
PLoS One. 2023; 18(2):e0282226.
PMID: 36827275
PMC: 9956025.
DOI: 10.1371/journal.pone.0282226.
Buoninfante A, Andeweg A, Baker A, Borad M, Crawford N, Dogne J
NPJ Vaccines. 2022; 7(1):141.
PMID: 36351906
PMC: 9643955.
DOI: 10.1038/s41541-022-00569-8.
Favaloro E, Clifford J, Leitinger E, Parker M, Sung P, Chunilal S
J Thromb Haemost. 2022; 20(12):2896-2908.
PMID: 36107495
PMC: 9828670.
DOI: 10.1111/jth.15881.
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
Rodriguez Y, Rojas M, Beltran S, Polo F, Camacho-Dominguez L, Morales S
J Autoimmun. 2022; 132:102898.
PMID: 36041291
PMC: 9399140.
DOI: 10.1016/j.jaut.2022.102898.
Immune Thrombocytopenia in Previously Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization): A Descriptive Research of 70 Instances With a Focus on Biomarkers, Predictive Outcomes, and Consequences.
Sharma K, Patel S, Patel Z, Patel K, Shah D, Doshi J
Cureus. 2022; 14(7):e26480.
PMID: 35923492
PMC: 9342832.
DOI: 10.7759/cureus.26480.
Vaccine safety: what systems are required to ensure public confidence in vaccines?.
Cheng A, Buttery J
Med J Aust. 2022; 217(4):189-190.
PMID: 35843626
PMC: 9349887.
DOI: 10.5694/mja2.51662.
Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
Dix C, McFadyen J, Huang A, Chunilal S, Chen V, Tran H
Intern Med J. 2022; 52(5):717-723.
PMID: 35446471
PMC: 9111818.
DOI: 10.1111/imj.15783.
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review.
Abrignani M, Murrone A, De Luca L, Roncon L, Lenarda A, Valente S
J Clin Med. 2022; 11(4).
PMID: 35207220
PMC: 8880092.
DOI: 10.3390/jcm11040948.
Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia.
Ihnatko M, Truchla I, Ihnatkova L, Prohaszka Z, Lazurova I
Front Med (Lausanne). 2022; 8:789972.
PMID: 35059416
PMC: 8764362.
DOI: 10.3389/fmed.2021.789972.
Cardiovascular and haematological events post COVID-19 vaccination: A systematic review.
Al-Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N
J Cell Mol Med. 2021; 26(3):636-653.
PMID: 34967105
PMC: 8817142.
DOI: 10.1111/jcmm.17137.
Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.
Waqar U, Ahmed S, Gardezi S, Tahir M, Abidin Z, Hussain A
Clin Appl Thromb Hemost. 2021; 27:10760296211068487.
PMID: 34907794
PMC: 8689609.
DOI: 10.1177/10760296211068487.
Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score.
Hwang J, Park S, Lee S, Lee S, Lee M, Jeong G
Eur Heart J. 2021; 42(39):4053-4063.
PMID: 34545400
PMC: 8500026.
DOI: 10.1093/eurheartj/ehab592.
Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia.
Chen V, Curnow J, Tran H, Choi P
Med J Aust. 2021; 215(6):245-249.e1.
PMID: 34490632
PMC: 8661608.
DOI: 10.5694/mja2.51229.